Caplin Point Laboratories Q1 Results
- BSE: 524742
- NSE: CAPLIPOINT
- ISIN: INE475E01026
- Sector: Biotechnology & Drugs
BSE
2,264.25
154.25 (7.31%)
154.25 (7.31%)Volume28.99 K
Updated: Tue 9 Jun, 2026 | 15:25:56
NSE
2,255.20144.20 (6.83%)
144.20 (6.83%)Volume6.15 L
Updated: Tue 9 Jun, 2026 | 15:45:36
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Caplin Point Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 348.75 | 414.72 | -0.76% | 323.11 | 7.94% |
| Depreciation/ Amortization | 16.29 | 18.80 | -4.40% | 15.96 | 2.07% |
| Operating Income | 161.47 | 185.44 | 6.92% | 135.85 | 18.86% |
| Net Income | 152.80 | 170.11 | 7.18% | 123.98 | 23.25% |
| Other Operating Expenses Total | 94.06 | 98.30 | 840.60% | 81.52 | 15.38% |
| Net Income Before Taxes | 184.46 | 213.44 | 4.41% | 154.38 | 19.48% |
| Total Revenue | 510.22 | 600.16 | 1.55% | 458.96 | 11.17% |
| Selling/ General/ Admin Expenses Total | 43.16 | 52.62 | -7.20% | 40.15 | 7.50% |
| Diluted Normalized EPS | 20.03 | 22.31 | 7.10% | 16.32 | 22.73% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.